Skip to content
sellWeak

Steven D Schwartz sold $148k of BIO

owner at BIO-RAD LABORATORIES, INC.. 320 shares at an average of $463.86, traded May 3, 2023, filed May 1, 2024.

Warning score
28
Value
$148k
320 shares
Holdings after
1,498
-18% from before
From 52-week low
+32%
low $351.71, close $463.86
From 52-week high
-18%
high $563.26, as of May 3, 2023

Score components

  • Role
    10% owner
    +12
  • Trade size
    $148k at market
    +11
  • Share of holdings sold
    Sold 18% of holdings
    +5
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +4.7%, 3m +23.5%, 6m +20.6%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

BIOOct 13, 2026 · close 363.73
Since filing May 1, 2024: +32.7%SPY +60.1% · excess -27.4%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001062993-24-009134, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
May 3, 2023SOpen-market sale
Bio-Rad A Common Stockindirect: By Spouse
-320$463.86$148k1,498May 1, 2024

Related signals

Other insiders at BIO-RAD LABORATORIES, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
46Moderate
BIOsell
BIO-RAD LABORATORIES, INC.
Eva Anette Engelhardt
EVP, President, CDG
$136k
550 shares
-61%
47Moderate
BIOsell
BIO-RAD LABORATORIES, INC.
James Barry
EVP, President, LSG
$214k
700 shares
-58%
31Weak
BIOsell
BIO-RAD LABORATORIES, INC.
Michael Crowley
EVP, GBL Commercial Operations
$741k
3,000 shares
-27%
48Moderate
BIOsell 2
BIO-RAD LABORATORIES, INC.
Andrew J. Last
EVP, Chief Operating Officer
$990k
3,000 shares
-28%
40Moderate
BIOsell 2
BIO-RAD LABORATORIES, INC.
James Barry
EVP, President, LSG
$206k
623 shares
-81%
25Weak
BIOsell
BIO-RAD LABORATORIES, INC.
Michael Crowley
EVP, GBL Commercial Operations
$104k
369 shares
-5%
41Moderate
BIOsell 2
BIO-RAD LABORATORIES, INC.
Timothy S Ernst
EVP, General Counsel & Sec
$826k
2,500 shares
-42%
43Moderate
BIOsell 2
BIO-RAD LABORATORIES, INC.
Michael Crowley
EVP, GBL Commercial Operations
$1.0M
3,000 shares
-30%
48Moderate
BIOsell 2
BIO-RAD LABORATORIES, INC.
Dara Wright
EVP, President, CDG
$359k
1,200 shares
-44%
35Weak
BIOsell 2
BIO-RAD LABORATORIES, INC.
Michael Crowley
EVP, GBL Commercial Operations
$196k
642 shares
-8%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Steven D Schwartz sold $148k of BIO | InsiderTell